Hyo-Yeon Kim

Ferulic acid protects against carbon tetrachloride-induced liver injury in mice

Hyo-Yeon Kim, Juhyun Park, Kwan-Hoo Lee et al. · Toxicology · 2011 · 170 citations

Hepatology, Biochemistry, Medicine +13

Clinical activity and safety of HM61713, an EGFR-mutant selective inhibitor, in advanced non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations who had received EGFR tyrosine kinase inhibitors (TKIs).

Dong‐Wan Kim, Dae Ho Lee, Jin Hyoung Kang et al. · Journal of Clinical Oncology · 2014 · 70 citations

Pathology, Pharmacotherapy, Arm B +20

Ferulic acid attenuates ischemia/reperfusion-induced hepatocyte apoptosis via inhibition of JNK activation

Hyo-Yeon Kim, Sun‐Mee Lee · European Journal of Pharmaceutical Sciences · 2012 · 60 citations

Hepatology, Biochemistry, Ischemia/reperfusion-induced Hepatocyte Apoptosis +14

Immunomodulating effects of Korean mistletoe lectin in vitro and in vivo

Chanho Lee, Joon-Ki Kim, Hyo-Yeon Kim et al. · International Immunopharmacology · 2009 · 47 citations

Clinical Immunology, Allergy, Autoimmune Disease +10

BI 1482694 (HM61713), an EGFR mutant-specific inhibitor, in T790M+ NSCLC: Efficacy and safety at the RP2D.

Keunchil Park, Jong-Seok Lee, Ki Hyeong Lee et al. · Journal of Clinical Oncology · 2016 · 41 citations

Oncology, Phase Ii, Malignant Disease +15